WSJ -- Sanofi-Aventis SA (SNY) is expected to decide in coming weeks whether to rekindle an animal-health joint venture with Merck & Co. (MRK) that would be even bigger than the partnership that was undone last year.
WSJ -- Sanofi-Aventis SA (SNY) is expected to decide in coming weeks whether to rekindle an animal-health joint venture with Merck & Co. (MRK) that would be even bigger than the partnership that was undone last year.
